Arthneeti

Patel Chem Specialities Share Price & Earnings Call Analysis

₹140.85-1.78% today
Market cap
₹350 Cr
P/E
27.91
ROE
18.61%
PEG
0.44
Price to sales
2.55
Debt to equity
0.15
52W high / low
₹163 / ₹57.8
Sales growth (5Y)
26.42%
EBITDA margin
12.45%
Net profit margin
9.15%
Promoter holding
68.90%
Sales (last year)
₹137 Cr

Incorporated in 2008, Patel Chem Specialities Limited (PCSL) is engaged in the manufacturing and exporting of pharmaceutical excipients and specialty chemicals.[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Patel Chem rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Patel Chem.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Patel Chem

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Patel Chem

Quarterly Results

Quarter-by-quarter operating performance

No quarterly results data available for this company yet.

Financials of Patel Chem

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +42606982105137
Expenses +4056647190120
Operating Profit245121517
OPM %6%7%8%14%15%12%
Other Income +000002
Interest011111
Depreciation001111
Profit before tax244101417
Tax %20%35%30%26%25%26%
Net Profit +12381113
EPS in Rs5.915.05
Dividend Payout %0%0%0%0%0%0%

Financials of Patel Chem

Balance Sheet

Capital structure and asset base

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital11111825
Reserves6811191875
Borrowings +6812151515
Other Liabilities +5713121528
Total Liabilities1823374765142
Fixed Assets +61014141430
CWIP00021215
Investments000000
Other Assets +131323313998
Total Assets1823374765142

Financials of Patel Chem

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-24226211
Cash from Investing Activity +-1,978-4-3-6-7-19
Cash from Financing Activity +332010544
Net Cash Flow-1,670-1-00036
Free Cash Flow-24-3-23-9-8
CFO/OP13,954%56%58%62%32%90%

Financials of Patel Chem

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days565879687379
Inventory Days151245646161
Days Payable473577525167
Cash Conversion Cycle253547798373
Working Capital Days-1619295751
ROCE %28%26%39%35%22%

Continue your research

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF